FindTrial
Sign In

microRNA-95 knockdown inhibits epithelial-mesenchymal transition and cancer stem cell phenotype in gastric cancer cells through MAPK pathway by up-regulating DUSP5

microRNA-95 knockdown inhibits epithelial-mesenchymal transition and cancer stem cell phenotype in gastric cancer cells through MAPK pathway by up-regulating DUSP5

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023686
Enrollment
Unknown
Registered
2019-06-07
Start date
2015-03-05
Completion date
Unknown
Last updated
2019-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

Case series:Surgery

Sponsors

Department of Gastroenterology, Linyi People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: The patients were cytologically or histologically diagnosed with GC, as well as with tumors that could be surgically resected by clinical evaluation. The participating patients were confirmed to have no history of other cancer in the digestive systems nor received any treatment prior to surgery (radiotherapy, chemotherapy, simultaneous radiotherapy and chemotherapy).

Exclusion criteria

Exclusion criteria: Patients with severe complications or complications.

Design outcomes

Primary

MeasureTime frame
relative expression of miR-95;—

Countries

China

Contacts

Public ContactAihua Wang

Department of Gastroenterology, Linyi People's Hospital

wahua1971@163.com+86 0539 8226999

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026